Pharmaceutical Company Announces Innovative Dry Eye Disease Treatment

OKYO Pharma's OK-101: A Revolutionary Treatment for Dry Eye Disease.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

Dry Eye Disease (DED) is a prevalent condition affecting millions globally, characterized by discomfort, visual disturbance, and potential damage to the ocular surface. Despite the availability of various treat…